Valeant Pharmaceuticals Intl
13F holders, Q2 2026 (June 30)1holders
0new positions
0sold out
$4.93avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Valeant Pharmaceuticals Intl in their 13F filings, unchanged from Q1 2026. 0 opened new positions and 0 sold out. The largest holder was Bruce & Co., Inc. ($611K).
- Company
- Valeant Pharmaceuticals Intl
- Filed as
- Bausch Health (Q2 2026)
- CUSIP
- 91911K102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Bruce & Co., Inc. | 0.17% | No change | 124,000 | $611K |
"% of holder's portfolio" is VALEANT PHARMACEUTICALS INTL's weight in each manager's 13F, not the share of Valeant Pharmaceuticals Intl the manager owns.